A number of states are moving reform bills concerning the study or straight out legalizing the use of psychedelic substances for therapeutic purposes. Others have already passed legislation and its implementation is underway. A short recap of the latest moves as of Sept. 7:
California: Senate-passed SB58 legalizing adult possession and cultivation of psilocybin, psilocin, DMT and mescaline has cleared the Assembly floor on Sept. 6 and now heads back to the Senate for concurrence on recent amendments, after which it will go to Gov. Newsom’s desk.
Changes affect provisions on substance transfer and therapeutic use, delay the decriminalization of communal use, and reduce personal possession amounts “until a framework for the therapeutic use, which would include community-based healing, facilitated and supported use, risk reduction, and other related services, of the specified controlled substances is developed and adopted.”
New allowed personal amounts: 1 gr. or up to one ounce of a plant or fungi containing either psilocybin or psilocin; 1 gr. of DMT; and 4 gr. of mescaline. Adults over 21 could possess an “amount of spores or mycelium capable of producing an allowable amount of a plant or fungi which contain a controlled substance” legalized under the bill.
Additionally, the revised bill calls on the California Health and Human Services Agency (CHHSA) to create a workgroup to study and recommend to the legislature the establishment of a regulatory framework for the facilitated therapeutic use of psychedelics by Jan. 2025.
Meanwhile, AB 1021 legalizing Schedule I controlled substances for “legitimate medical purposes” was ordered a third reading in the Senate after which it …